Clinical Journal of the American Society of Nephrology

Surrogate Endpoints in APOL1-Associated Kidney Disease: Evaluation in Three Cohorts
Rosenberg A, Flaherty C, Anderson A, Appel LJ, Coresh J, He J, Lash J, Liu C, Rao P, Taliercio J, Surapaneni A, Grams M and
Surrogate endpoints for the clinical outcome of kidney failure have been accepted by the United States Food and Drug Administration. However, they have not been specifically evaluated in Apolipoprotein L1 (APOL1)-associated kidney disease.
CJASN: A Prelude to the Future
Rhee CM and
Benefits and Harms of Coronary Revascularization in Non-Dialysis-Dependent Chronic Kidney Disease and Ischemic Heart Disease: A Systematic Review and Meta-Analysis
Patel DM, Wilson LM, Wilson RF, Yang X, Gharibani T and Robinson KA
Exercise and Cognition in People with Chronic Kidney Disease
Scholes-Robertson N
Social Determinants of Health in Acute Kidney Injury: Looking Beyond the Hospital Room
Williams AE and Diamantidis CJ
Whole Grains, Refined Grains, and Diet Quality in Chronic Kidney Disease
Fleig S and Kuhlmann MK
Bisphosphonate Use After Kidney Transplantation Is Associated with Lower Fracture Risk
Kahwaji JM, Yang SJ, Sim J, Parke CY and Lee RL
Kidney transplant recipients are at higher risk of fractures compared to the general population. The use of bisphosphonates has been shown to increase bone mineral density after transplantation but has not been shown to lower fracture rates. Here, we aim to determine if exposure to bisphosphonates associates with lower incidence of non-vertebral fractures after kidney transplantation.
Fat Distribution and Urolithiasis Risk Parameters in Uric Acid Stone Formers and Patients with Type 2 Diabetes Mellitus
Zomorodian A, Li X, Poindexter J, Maalouf NM, Sakhaee K and Moe OW
Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis
Pinter J, Canaud B, Mayne KJ, Stuard S, Moissl U, Kooman J, Jager KJ, Chesnaye NC, Smyth B and Genser B
Abnormal fluid and plasma sodium concentrations are established prognostic factors for patients on hemodialysis. However, the cumulative effects of abnormal salt and water and potential effect modifications and the effect of dialysate sodium remain incompletely understood.
Cardiopulmonary Exercise Testing in Patients with Chronic Kidney Disease
Tuttle M and Sarnak MJ
Cancer Screening among Patients with Kidney Failure Requiring Hemodialysis: Where We Are and Where We Are Going
Jayaram D and Golestaneh L
Urinary Response to Consuming Plant-Based Meat Alternatives in Persons with Normal Kidney Function: The SWAP-MEAT Pilot Trial
Ward CP, Landry MJ, Cunanan KM, Raphael KL, Dant CC, Gardner CD and Pao AC
Consuming excess animal meat may exacerbate kidney disorders, such as urinary stone disease and CKD. Plant-based meat alternatives imitate animal meat and replace animal with vegetable protein, but it is unclear whether eating plant-meat confers similar health benefits as eating whole vegetables. We hypothesized that eating plant-meat when compared with animal meat decreases dietary acid load but increases dietary phosphorus and nitrogen.
Risk of Surgical Site Infections after Tooth Extraction in Chronic Kidney Disease: A Retrospective Real-World Study in Japan
Ishimaru M, Ono S, Iwagami M, Miyamoto Y, Mikami R and Aida J
Reliability of GFR Estimated by Creatinine-Based Formulas in Moderate-to-Severe Proteinuria
Zoccali C, Provenzano PF, Tripepi G, Carrara F, Mallamaci F, Perna A, Delanaye P, Ruggenenti P and Remuzzi G
Exploring the Challenges and Limitations in Participation of Women Nephrologists in Conferences: A Pilot Study
Meena P, Arellano-Mendez D, Calice-Silva V, Bek SG, Tomacruz Amante ID, Yadla M, Mohan K, Bajpai D, Shankar M, Java A, Soki K, Arce-Amare F, Luyckx V, Karam S and
Baseline, Early Changes, and Residual Albuminuria: Post-hoc Analysis of a Clinical Trial of Dapagliflozin in Chronic Kidney Disease
van Mil D, Vart P, Chertow GM, Gansevoort RT, Rossing P, Toto RD, Correa-Rotter R, Langkilde AM, Sjöström CD, Wheeler DC and Heerspink HJL
Albuminuria is a strong indicator of kidney and cardiovascular risk in patients with chronic kidney disease (CKD). We assessed risk associations between albuminuria at baseline and four months after randomization in a placebo-controlled trial of dapagliflozin and kidney endpoints in patients with CKD and albuminuria, with and without type 2 diabetes.
Early Effects of the End-Stage Renal Disease Treatment Choices Model on Kidney Transplant Waitlist Additions
Potluri VS, Reddy YNV, Tummalapalli SL, Peng C, Huang Q, Zhao Y, Kanter GP, Zhu J, Liao JM and Navathe A
Despite the mortality benefit of kidney transplantation over dialysis, only 13% of patients with end-stage kidney disease are on the transplant waitlist. Given the low rates of transplant waitlisting in the US, Medicare launched the End-Stage Renal Disease Treatment Choices (ETC) Model in 2021, the largest mandatory trial of payment incentives in kidney disease, which randomized 30% of healthcare markets to financial bonuses/penalties to improve kidney transplantation and home dialysis use. This study examines the effect of ETC payment adjustments on US kidney transplant waitlist additions.
Neighborhood Socioeconomic Deprivation is Associated with Worse Outcomes in Pediatric Kidney Transplant Recipients
Douglas CE, Bradford MC, Engen RM, Ng YH, Wightman A, Mokiao R, Bartosh S, Dick AAS and Smith JM
Social determinants of health shape a child's transplant course. We describe the association between neighborhood socioeconomic deprivation, transplant characteristics, and graft survival in US pediatric kidney transplant recipients.
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins
Kobayashi H, Looker HC, Ihara K, Md Dom ZI, Satake E, Tye SC, Duffin KL, Doria A, Nelson RG and Krolewski AS
Limited knowledge exists regarding short-term changes/increases in concentrations of circulating proteins (referred here as deltas) and rapid development of kidney failure (rapid KF) in diabetes mellitus.
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials
Mendonça L, Moura H, Chaves PC, Neves JS and Ferreira JP
Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKD
Ahmadi A, Gamboa J, Norman JE, Enkhmaa B, Tucker M, Bennett BJ, Zelnick LR, Fan S, Berglund LF, Ikizler TA, de Boer IH, Cummings BP and Roshanravan B